{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T14:00:23Z","timestamp":1774879223813,"version":"3.50.1"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T00:00:00Z","timestamp":1665014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with multi-organ inflammation and defect, which is linked to many molecule mediators. Oxylipins as a class of lipid mediator have not been broadly investigated in SLE. Here, we applied targeted mass spectrometry analysis to screen the alteration of oxylipins in serum of 98 SLE patients and 106 healthy controls. The correlation of oxylipins to lupus nephritis (LN) and SLE disease activity, and the biomarkers for SLE classification, were analyzed. Among 128 oxylipins analyzed, 92 were absolutely quantified and 26 were significantly changed. They were mainly generated from the metabolism of several polyunsaturated fatty acids, including arachidonic acid (AA), linoleic acid (LA), docosahexanoic acid (DHA), eicosapentanoic acid (EPA) and dihomo-\u03b3-linolenic acid (DGLA). Several oxylipins, especially those produced from AA, showed different abundance between patients with and without lupus nephritis (LN). The DGLA metabolic activity and DGLA generated PGE1, were significantly associated with SLE disease activity. Random forest-based machine learning identified a 5-oxylipin combination as potential biomarker for SLE classification with high accuracy. Seven individual oxylipin biomarkers were also identified with good performance in distinguishing SLE patients from healthy controls (individual AUC &amp;gt; 0.7). Interestingly, the biomarkers for differentiating SLE patients from healthy controls are distinct from the oxylipins differentially expressed in LN patients <jats:italic>vs.<\/jats:italic> non-LN patients. This study provides possibilities for the understanding of SLE characteristics and the development of new tools for SLE classification.<\/jats:p>","DOI":"10.3389\/fimmu.2022.964901","type":"journal-article","created":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T11:20:57Z","timestamp":1665055257000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Absolute quantification and characterization of oxylipins in lupus nephritis and systemic lupus erythematosus"],"prefix":"10.3389","volume":"13","author":[{"given":"Jingquan","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiyu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donge","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaoyun","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengping","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhipeng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongzhou","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoping","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weier","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lianghong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2016.186","article-title":"New insights into the immunopathogenesis of systemic lupus erythematosus","volume":"12","author":"Tsokos","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2012.208","article-title":"Global trends, potential mechanisms and early detection of organ damage in SLE","volume":"9","author":"Mak","year":"2013","journal-title":"Nat Rev Rheumatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-031850","article-title":"Association between organ damage and mortality in systemic lupus erythematosus: a systematic review and meta-analysis","volume":"10","author":"Murimi-Worstell","year":"2020","journal-title":"BMJ Open"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2015.151","article-title":"Anti-DNA antibodies\u2013quintessential biomarkers of SLE","volume":"12","author":"Pisetsky","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216312","article-title":"Quantitative planar array screen of 1000 proteins uncovers novel urinary protein biomarkers of lupus nephritis","volume":"79","author":"Vanarsa","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B6","article-title":"One year in review 2019: Systemic lupus erythematosus","volume":"37","author":"Zucchi","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-020-0480-7","article-title":"New insights into the role of antinuclear antibodies in systemic lupus erythematosus","volume":"16","author":"Pisetsky","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1136\/annrheumdis-2013-203863","article-title":"International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies","volume":"73","author":"Agmon-Levin","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2019.102374","article-title":"Inflammatory markers in systemic lupus erythematosus","volume":"110","author":"Aringer","year":"2020","journal-title":"J Autoimmun"},{"key":"B10","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1136\/ard.62.1.37","article-title":"Immune complexes from SLE sera induce IL10 production from normal peripheral blood mononuclear cells by an FcgammaRII dependent mechanism: implications for a possible vicious cycle maintaining b cell hyperactivity in SLE","volume":"62","author":"R\u00f6nnelid","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.03.008","article-title":"Personalized immunomonitoring uncovers molecular networks that stratify lupus patients","volume":"165","author":"Banchereau","year":"2016","journal-title":"Cell"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-020-0743-0","article-title":"Mapping systemic lupus erythematosus heterogeneity at the single-cell level","volume":"21","author":"Nehar-Belaid","year":"2020","journal-title":"Nat Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-020-0503-4","article-title":"Sex steroids and autoimmune rheumatic diseases: State of the art","volume":"16","author":"Cutolo","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jchromb.2014.01.046","article-title":"Liquid chromatography-tandem mass spectrometry for the analysis of eicosanoids and related lipids in human biological matrices: A review","volume":"964","author":"Kortz","year":"2014","journal-title":"J Chromatogr B Analyt Technol BioMed Life Sci"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/nri3859","article-title":"Eicosanoid storm in infection and inflammation","volume":"15","author":"Dennis","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.it.2013.10.008","article-title":"Lipid mediators in immune dysfunction after severe inflammation","volume":"35","author":"Fullerton","year":"2014","journal-title":"Trends Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"eabc8059","DOI":"10.1126\/science.abc8059","article-title":"Inhibition of prostaglandin-degrading enzyme 15-PGDH rejuvenates aged muscle mass and strength","volume":"371","author":"Palla","year":"2021","journal-title":"Science"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/art.41537","article-title":"Profiling of serum oxylipins during the earliest stages of rheumatoid arthritis","volume":"73","author":"Rodr\u00edguez-Carrio","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41392-020-00443-w","article-title":"Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00512","article-title":"Epoxyeicosatrienoic acid analog EET-a blunts development of lupus nephritis in mice","volume":"10","author":"Hye Khan","year":"2019","journal-title":"Front Pharmacol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112053","article-title":"Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus","volume":"76","author":"Patrono","year":"1985","journal-title":"J Clin Invest."},{"key":"B22","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/s41467-018-03129-8","article-title":"Prostaglandin D(2) amplifies lupus disease through basophil accumulation in lymphoid organs","volume":"9","author":"Pellefigues","year":"2018","journal-title":"Nat Commun"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01703","article-title":"Microbiome and metabolome analyses reveal the disruption of lipid metabolism in systemic lupus erythematosus","volume":"11","author":"He","year":"2020","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214819","article-title":"European League against Rheumatism\/American college of rheumatology classification criteria for systemic lupus erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780350606","article-title":"Derivation of the SLEDAI. a disease activity index for lupus patients. The committee on prognosis studies in SLE","volume":"35","author":"Bombardier","year":"1992","journal-title":"Arthritis Rheumatol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky310","article-title":"MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis","volume":"46","author":"Chong","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1000217","article-title":"Inferring pathway activity toward precise disease classification","volume":"4","author":"Lee","year":"2008","journal-title":"PloS Comput Biol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.chroma.2014.07.006","article-title":"Comprehensive ultra-performance liquid chromatographic separation and mass spectrometric analysis of eicosanoid metabolites in human samples","volume":"1359","author":"Wang","year":"2014","journal-title":"J Chromatogr A."},{"key":"B29","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.freeradbiomed.2019.05.012","article-title":"MS-based targeted metabolomics of eicosanoids and other oxylipins: Analytical and inter-individual variabilities","volume":"144","author":"Gladine","year":"2019","journal-title":"Free Radic Biol Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1093\/rheumatology\/keaa126","article-title":"Metabolomic profiling reveals serum l-pyroglutamic acid as a potential diagnostic biomarker for systemic lupus erythematosus","volume":"60","author":"Zhang","year":"2021","journal-title":"Rheumatol (Oxford)."},{"key":"B31","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1177\/0148607110386378","article-title":"Alterations in circulating fatty acid composition in patients with systemic lupus erythematosus: A pilot study","volume":"35","author":"Aghdassi","year":"2011","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"B32","first-page":"72","article-title":"Decreased release of leukotriene B4 from monocytes and polymorphonuclear leukocytes in patients with systemic lupus erythematosus","volume":"40","author":"Shome","year":"1991","journal-title":"Arerugi"},{"key":"B33","article-title":"Decreased arachidonic acid release in peripheral blood monocytes of patients with systemic lupus erythematosus","volume":"28","author":"Sipka","year":"2001","journal-title":"J Rheumatol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-016-8892-9","article-title":"Dyslipidemia in systemic lupus erythematosus","volume":"65","author":"Szab\u00f3","year":"2017","journal-title":"Immunol Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2013.147","article-title":"Oxidative stress in the pathology and treatment of systemic lupus erythematosus","volume":"9","author":"Perl","year":"2013","journal-title":"Nat Rev Rheumatol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2007.03.023","article-title":"Phase 2 enzyme induction by conjugated linoleic acid improves lupus-associated oxidative stress","volume":"43","author":"Bergamo","year":"2007","journal-title":"Free Radic Biol Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/art.34502","article-title":"N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial","volume":"64","author":"Lai","year":"2012","journal-title":"Arthritis Rheumatol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/s0952-3278(97)90533-0","article-title":"Oxidant stress, anti-oxidants and essential fatty acids in systemic lupus erythematosus","volume":"56","author":"Mohan","year":"1997","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01477","article-title":"Immunomodulatory effects of diet and nutrients in systemic lupus erythematosus (SLE): A systematic review","volume":"11","author":"Islam","year":"2020","journal-title":"Front Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.116.308050","article-title":"12(S)-HETrE, a 12-lipoxygenase oxylipin of dihomo-\u03b3-Linolenic acid, inhibits thrombosis via g\u03b1s signaling in platelets","volume":"36","author":"Yeung","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2017.02.022","article-title":"Serum dihomo-\u03b3-linolenic acid level is inversely associated with the risk of depression. A 21-year follow-up study in general population men","volume":"213","author":"Yary","year":"2017","journal-title":"J Affect Disord"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0037210","article-title":"Metabolic disturbances associated with systemic lupus erythematosus","volume":"7","author":"Wu","year":"2012","journal-title":"PloS One"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.964901\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T11:21:05Z","timestamp":1665055265000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.964901\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,6]]},"references-count":42,"alternative-id":["10.3389\/fimmu.2022.964901"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.964901","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,6]]},"article-number":"964901"}}